FDA Inspection 1305600 — Anika Therapeutics, Inc.
The FDA completed an inspection of Anika Therapeutics, Inc. on Apr 13, 2026 in Bedford, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 13, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Bedford, MA (United States)